Overview:
With the development of antibody-drug conjugates and immune checkpoint inhibitors, the treatment of both adult and pediatric patients with advanced Hodgkin lymphoma (HL) is undergoing a transformation. New therapeutic targets are also emerging for patients with relapsed/refractory disease. Thus, there is a need for education regarding current and emerging novel therapeutic approaches in the management of HL.
This How We Do It® symposium will bring together clinical experts in lymphoma to highlight evolving approaches to the diagnosis and treatment of patients with HL. Evidence-based assessments of current standards of practice and the most important clinical trials will set the stage for extensive case-based discussion sessions, which will address newly diagnosed patients, relapsed/refractory disease, and pediatric patients. Additionally, strategies to maximize the safety of treatment regimens in patients with HL will be evaluated.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Develop personalized care plans for patients with HL based on patient-related factors, risk stratification and treatment history
- Explain the efficacy and safety of evolving adult and pediatric strategies for advanced HL from clinical trials, including real world evidence in multiple lines of care
- Apply proactive strategies to recognize and manage adverse events associated with the use of novel therapies for the management of adult and pediatric patients with advanced HL
- Utilize evidence to develop case-based strategies for the management of adult and pediatric patients with HL
Program Chair:
Joseph M. Connors, MD, CM
To view full profile, click on the Program Chair tab above.
Joseph M. Connors, MD, CM
Professor Emeritus
BC Cancer Centre for Lymphoid Cancer
Department of Medicine
University of British Columbia
Vancouver, BC, Canada
Craig H. Moskowitz, MD
Physician-in-Chief, Oncology Service Line
Sylvester Comprehensive Cancer Center
Professor of Medicine, Division of Hematology
University of Miami Health System
Miami, FL
Paul Harker-Murray, MD
Professor at Medical College of Wisconsin
Milwaukee, WI
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.
